These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29681440)

  • 1. Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program.
    Papastergiou J; Trieu CR; Saltmarche D; Diamantouros A
    J Am Pharm Assoc (2003); 2018; 58(4):450-456. PubMed ID: 29681440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
    Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
    J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
    Dong BJ; Lopez M; Cocohoba J
    J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a community pharmacy-based influenza and group A streptococcal pharyngitis disease management program using polymerase chain reaction point-of-care testing.
    Klepser DG; Klepser ME; Murry JS; Borden H; Olsen KM
    J Am Pharm Assoc (2003); 2019; 59(6):872-879. PubMed ID: 31474527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of influenza and streptococcal pharyngitis point-of-care testing in the community pharmacy practice setting.
    Klepser DG; Klepser ME; Smith JK; Dering-Anderson AM; Nelson M; Pohren LE
    Res Social Adm Pharm; 2018 Apr; 14(4):356-359. PubMed ID: 28479019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
    Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
    BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observation of a Pharmacist-Conducted Group A Streptococcal Pharyngitis Point-of-Care Test: A Time and Motion Study.
    Corn CE; Klepser DG; Dering-Anderson AM; Brown TG; Klepser ME; Smith JK
    J Pharm Pract; 2018 Jun; 31(3):284-291. PubMed ID: 28553774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting.
    Kirby J; Mousa N
    J Am Pharm Assoc (2003); 2020; 60(3S):S70-S75. PubMed ID: 32253085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacist-physician collaborative streptococcal pharyngitis management program.
    Klepser DG; Klepser ME; Dering-Anderson AM; Morse JA; Smith JK; Klepser SA
    J Am Pharm Assoc (2003); 2016; 56(3):323-329.e1. PubMed ID: 27067554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid antigen test use for the management of group A streptococcal pharyngitis in community pharmacies.
    Demoré B; Tebano G; Gravoulet J; Wilcke C; Ruspini E; Birgé J; Boivin JM; Hénard S; Dieterling A; Munerol L; Husson J; Rabaud C; Pulcini C; Malblanc S
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1637-1645. PubMed ID: 29876774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacy rapid influenza A and B screening: A novel approach to expedite patient access to care and improve clinical outcomes.
    Papastergiou J; Folkins C; Li W; Young L
    Can Pharm J (Ott); 2016 Mar; 149(2):83-9. PubMed ID: 27076819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care C-reactive protein testing to support the management of respiratory tract infections in community pharmacy: A feasibility study.
    Sim TF; Chalmers L; Czarniak P; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B
    Res Social Adm Pharm; 2021 Oct; 17(10):1719-1726. PubMed ID: 33500197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records.
    Mantzourani E; Wasag D; Cannings-John R; Ahmed H; Evans A
    J Antimicrob Chemother; 2022 Dec; 78(1):84-92. PubMed ID: 36272134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.
    Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB
    J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of diagnosis of streptococcal pharyngitis among Thai community pharmacists according to the Centor criteria.
    Saengcharoen W; Jaisawang P; Udomcharoensab P; Buathong K; Lerkiatbundit S
    Int J Clin Pharm; 2016 Oct; 38(5):1318-25. PubMed ID: 27573720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do community pharmacist performance evaluations capture the modern pharmacist's role? Mapping competencies assessed in Canadian community pharmacy performance evaluation templates against the General Level Framework.
    Chong IYM; Rosenthal MM; Manson KR; Houle SKD
    J Am Pharm Assoc (2003); 2018; 58(6):638-642.e2. PubMed ID: 30237009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To swab or not to swab? Using point-of-care tests to detect Group A Streptococcus infections as part of a Sore Throat Test and Treat service in community pharmacy.
    Mantzourani E; Cannings-John R; Evans A; Ahmed H
    J Antimicrob Chemother; 2022 Feb; 77(3):803-806. PubMed ID: 35038341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.